Day: December 2, 2022

Notice of redemption of convertible bonds PKG5

Notice of redemption of convertible bonds PKG5

Notice of redemption of convertible bonds PKG5 AS Pro Kapital Grupp informs that it is redeeming 24 500 “EEK 7.00 PRO KAPITAL GRUPP CONV. BOND PKG5 10-2020” convertible bonds (with ISINEE3300109917) in total nominal value of 245 000 Estonian kroons and issue value of 68 600 euros and has submitted the Nasdaq Central Depository of Securities the application to delete the bonds from the register. The convertible bonds bore an annual interest of 7%. The issue price of each convertible bond was 2.80 euros. The list of bondholders was fixed on 29 November 2022 and redemption payment will be made on 13 December 2022.   Edoardo Axel Preatoni Member of the Management Board +372 614 4920prokapital@prokapital.ee  

Continue reading

Notice of redemption of convertible bonds PKG5

Notice of redemption of convertible bonds PKG5

Notice of redemption of convertible bonds PKG5 AS Pro Kapital Grupp informs that it is redeeming 24 500 “EEK 7.00 PRO KAPITAL GRUPP CONV. BOND PKG5 10-2020” convertible bonds (with ISINEE3300109917) in total nominal value of 245 000 Estonian kroons and issue value of 68 600 euros and has submitted the Nasdaq Central Depository of Securities the application to delete the bonds from the register. The convertible bonds bore an annual interest of 7%. The issue price of each convertible bond was 2.80 euros. The list of bondholders was fixed on 29 November 2022 and redemption payment will be made on 13 December 2022. Edoardo Axel Preatoni Member of the Management Board +372 614 4920prokapital@prokapital.ee  

Continue reading

Stelmine acquires three new properties in the de Caniapiscau district

Stelmine acquires three new properties in the de Caniapiscau district

QUEBEC CITY, Dec. 02, 2022 (GLOBE NEWSWIRE) — Stelmine Canada (« Stelmine ») (TSXV : STH). Stelmine maintains its aggressive strategy of acquiring mining properties in the Caniapiscau mining district. The Company is adding 326 new claims to his portfolio bringing the total to 1775 claims covering 936 km2. This scenario allows the Company to protect his dominant land position and develop this new district while taking advantage of high potential mineral targets. In addition to the gold potential, the mineralization discovered on these three new properties should help Stelmine reach its objective of diversifying its portfolio and actively engage in the exploration of strategic metals such as nickel and some base metals while pursuing the advancement of its gold properties. Undoubtedly, during the last five years, Stelmine took the...

Continue reading

Horizon Therapeutics plc

Horizon Therapeutics plc

                        FORM 8.3   IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE   1. KEY INFORMATION   Name of person dealing (Note 1) State Street Global Advisors & Affiliates Company dealt in Horizon Therapeutics plc Class of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 ordinary shares Date of dealing 01st Dec 2022         2. INTERESTS AND SHORT POSITIONS   (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)     Long Short   Number (%) Number (%) (1) Relevant securities 5,916,453 2.61001%     (2) Derivatives (other than options) 508 0.000224%     (3) Options and agreements to purchase/sell N/A N/A     Total 5,916,961 2.61024%         (b)...

Continue reading

Horizon Therapeutics plc

Horizon Therapeutics plc

                        FORM 8.3   IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE   1. KEY INFORMATION   Name of person dealing (Note 1) State Street Global Advisors & Affiliates Company dealt in Horizon Therapeutics plc Class of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 ordinary shares Date of dealing 29th Nov 2022         2. INTERESTS AND SHORT POSITIONS   (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)     Long Short   Number (%) Number (%) (1) Relevant securities 5,889,421 2.59809%     (2) Derivatives (other than options) 508 0.000224%     (3) Options and agreements to purchase/sell N/A N/A     Total 5,889,929 2.59831%         (b)...

Continue reading

CareCloud To Host Virtual Analyst and Investor Day

CareCloud To Host Virtual Analyst and Investor Day

SOMERSET, N.J., Dec. 02, 2022 (GLOBE NEWSWIRE) — CareCloud, Inc. (the “Company”) (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced they will host an inaugural Analyst and Investor Day from 1 to 3 p.m. EST on Monday, December 12, 2022 using a live webcast. CareCloud leadership team will use this virtual event to share with participants their historic vision to transform the healthcare industry through high-quality technology, world-class operations and exciting new products. For 20 years, CareCloud has been a pillar in the healthcare technology space, helping healthcare providers deliver a premium, high-value experience for every patient. The Company is at the forefront of the industry’s shift to digitization and a value-based care model, with...

Continue reading

Horizon Therapeutics plc

Horizon Therapeutics plc

                        FORM 8.3   IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE   1. KEY INFORMATION   Name of person dealing (Note 1) State Street Global Advisors & Affiliates Company dealt in Horizon Therapeutics plc Class of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 ordinary shares Date of dealing 28th Nov 2022         2. INTERESTS AND SHORT POSITIONS   (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)     Long Short   Number (%) Number (%) (1) Relevant securities 5,905,507 2.60519%     (2) Derivatives (other than options) 508 0.000224%     (3) Options and agreements to purchase/sell N/A N/A     Total 5,906,015 2.60541%         (b)...

Continue reading

SeaStar Medical Bolsters Operational Expertise with Appointment of Thomas R. Mullen as Vice President of Operations and Product Development

SeaStar Medical Bolsters Operational Expertise with Appointment of Thomas R. Mullen as Vice President of Operations and Product Development

DENVER, COLORADO, Dec. 02, 2022 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq:ICU), (“SeaStar Medical” or the “Company”), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, today announced the appointment of Thomas R. Mullen as Vice President of Operations and Product Development. Mr. Mullen is a proven medical device professional with 30 years of experience leading business operations, manufacturing, engineering, product development and regulatory remediation. “SeaStar Medical has continued to evolve and remains on a trajectory of growth including near-term potential for commercialization. As we continue our preparations for success in treating both acute and chronic illnesses through advanced product offerings, we believe Tom’s extensive...

Continue reading

HIGHCO: Shareholding as 11-30-2022

HIGHCO: Shareholding as 11-30-2022

INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers (AMF) Date of settlementof information Total number of shares Number of shares without voting rights (*) Number of voting rights for threshold calculation (**) Number of actual voting rights (exercisable at shareholders’ meeting) November 30, 2022 20 455 403 177 280 23 012 201 22 834 921 October 31, 2022 20 455 403 145 022 23 048 421 22 903 399 September 30, 2022 20 455 403 90 180 23 050 521 22 960 341 August 31, 2022 20 455 403 83 843 23 050 522 22 966 679 July 31, 2022 20 455 403 82 029 23 050 622 22 968 593 July 2, 2022 (***) 20 455 403 78 771 23 050 722 22 971 951 June 30, 2022 22 421 332 2 044 700 25 016...

Continue reading

Skyharbour Resources Receives $895,000 from Warrant Exercises

Skyharbour Resources Receives $895,000 from Warrant Exercises

Vancouver, BC, Dec. 02, 2022 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce it has received an aggregate CAD $895,027.32 from the exercise of share purchase warrants with a strike price at $0.22 since June 29th, 2022. A total of 4,068,306 warrants have been exercised with this batch of warrants expiring November 29th, 2022. About Skyharbour Resources Ltd.: Skyharbour holds an extensive portfolio of uranium exploration projects in Canada’s Athabasca Basin and is well positioned to benefit from improving uranium market fundamentals with fifteen projects, ten of which are drill-ready, covering over 450,000 hectares of land. Skyharbour has acquired from Denison Mines, a large strategic shareholder of the Company, a 100% interest in the Moore Uranium...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.